Benazepril

This classification denotes an ace inhibitor with the molecular formula C24H28N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UDM7Q7QWP8, chemically known as 1h-1-benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (s-(r*,r*))- but generally known as benazepril, which bears US NIH Compound Identifier 5362124. Benazepril most often comes in base and hydrochloride forms. European Medicines Agency schedules Benazepril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05700MIG. The term BENAZEPRIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, No. 3, 1988, List 28). World Health Organization schedules benazepril in its Anatomical Therapeutic Chemical (ATC) Classification. BENAZEPRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benazepril under HS 29337900 and SITC 51561. As of Q4 2014, BENAZEPRIL remains the US FDA Preferred Term for this commodity. Benazepril bears US NLM identifiers UMLS ID C0053091 and NCI Concept Code C61645. SMILES: O=C1N(c2c(CCC1NC(CCc1ccccc1)C(=O)OCC)cccc2)CC(=O)O.